SG Americas Securities LLC Has $16.59 Million Stock Position in Hims & Hers Health, Inc. $HIMS

SG Americas Securities LLC raised its stake in Hims & Hers Health, Inc. (NYSE:HIMS) by 2,644.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 332,868 shares of the company’s stock after acquiring an additional 320,740 shares during the quarter. SG Americas Securities LLC owned about 0.15% of Hims & Hers Health worth $16,593,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of HIMS. Meridian Wealth Management LLC acquired a new position in Hims & Hers Health during the 2nd quarter worth $341,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in shares of Hims & Hers Health by 10.2% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 50,375 shares of the company’s stock worth $2,511,000 after acquiring an additional 4,672 shares during the last quarter. Foundations Investment Advisors LLC acquired a new position in shares of Hims & Hers Health during the second quarter valued at $407,000. Candriam S.C.A. bought a new position in Hims & Hers Health in the second quarter valued at about $4,426,000. Finally, Police & Firemen s Retirement System of New Jersey increased its position in Hims & Hers Health by 3.6% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 43,187 shares of the company’s stock worth $2,153,000 after purchasing an additional 1,490 shares during the period. Institutional investors and hedge funds own 63.52% of the company’s stock.

Hims & Hers Health Price Performance

HIMS opened at $37.09 on Friday. The stock has a market cap of $8.44 billion, a P/E ratio of 68.68, a P/E/G ratio of 7.36 and a beta of 2.20. Hims & Hers Health, Inc. has a 12 month low of $19.15 and a 12 month high of $72.98. The company has a quick ratio of 1.64, a current ratio of 1.88 and a debt-to-equity ratio of 1.67. The company has a fifty day simple moving average of $50.63 and a 200 day simple moving average of $51.33.

Hims & Hers Health (NYSE:HIMS) last posted its earnings results on Monday, November 3rd. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.03). The business had revenue of $598.98 million during the quarter, compared to analyst estimates of $578.99 million. Hims & Hers Health had a net margin of 6.05% and a return on equity of 24.67%. The firm’s revenue was up 49.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.32 earnings per share. Hims & Hers Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. On average, research analysts expect that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have weighed in on HIMS shares. Truist Financial dropped their price objective on Hims & Hers Health from $48.00 to $37.00 and set a “hold” rating for the company in a report on Monday, August 18th. Wall Street Zen downgraded shares of Hims & Hers Health from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Zacks Research cut shares of Hims & Hers Health from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 19th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Hims & Hers Health in a report on Tuesday. Finally, KeyCorp initiated coverage on Hims & Hers Health in a report on Tuesday, October 21st. They issued a “sector weight” rating for the company. Two investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average price target of $45.27.

Insider Activity

In related news, CEO Andrew Dudum sold 128,127 shares of the company’s stock in a transaction on Monday, August 18th. The shares were sold at an average price of $45.06, for a total value of $5,773,402.62. Following the completion of the transaction, the chief executive officer directly owned 89,521 shares of the company’s stock, valued at approximately $4,033,816.26. This represents a 58.87% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Oluyemi Okupe sold 145,000 shares of the stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $55.35, for a total value of $8,025,750.00. Following the transaction, the chief financial officer owned 128,984 shares of the company’s stock, valued at approximately $7,139,264.40. This trade represents a 52.92% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 712,336 shares of company stock worth $37,611,319 over the last quarter. 13.71% of the stock is currently owned by company insiders.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.